Sort   by:  
 Page size 
ProteomicsReverse phase protein array based protein profiling of breast cancer specimens
Expression levels of proteins and phosphoproteins, covering major cancer signaling pathways with a special focus on breast cancer biology, were obtained for a series of 109 breast cancer tumor specimens with positive estrogen receptor status. Tumor specimens from patients diagnosed with primary inva...
ORGANISM(S): Homo sapiens 
2014-02-18 | E-GEOD-47066 | biostudies-arrayexpress
ProteomicsReverse phase protein array based protein profiling of breast cancer specimens (2)
Expression levels of proteins and phosphoproteins, covering major cancer signaling pathways with a special focus on breast cancer biology, were obtained for a series of 164 breast cancer tumor specimens with positive estrogen receptor status. Tumor specimens from patients diagnosed with primary inva...
ORGANISM(S): Homo sapiens 
2014-02-18 | E-GEOD-50861 | biostudies-arrayexpress
Models,MultiomicsSKBR3 Breast Cell Line Long-term ErbB Network
Background Despite promising progress in targeted breast cancer therapy, drug resistance remains challenging. The monoclonal antibody drugs trastuzumab and pertuzumab as well as the small molecule inhibitor erlotinib were designed to prevent ErbB-2 and ErbB-1 receptor induced deregulated protein sig...
2703 | Cell Collective
Models,MultiomicsBT474 Breast Cell Line Long-term ErbB Network
Background Despite promising progress in targeted breast cancer therapy, drug resistance remains challenging. The monoclonal antibody drugs trastuzumab and pertuzumab as well as the small molecule inhibitor erlotinib were designed to prevent ErbB-2 and ErbB-1 receptor induced deregulated protein sig...
2697 | Cell Collective
Models,MultiomicsHCC1954 Breast Cell Line Long-term ErbB Network
Background Despite promising progress in targeted breast cancer therapy, drug resistance remains challenging. The monoclonal antibody drugs trastuzumab and pertuzumab as well as the small molecule inhibitor erlotinib were designed to prevent ErbB-2 and ErbB-1 receptor induced deregulated protein sig...
2698 | Cell Collective
Models,MultiomicsBT474 Breast Cell Line Short-term ErbB Network
Background Despite promising progress in targeted breast cancer therapy, drug resistance remains challenging. The monoclonal antibody drugs trastuzumab and pertuzumab as well as the small molecule inhibitor erlotinib were designed to prevent ErbB-2 and ErbB-1 receptor induced deregulated protein sig...
2699 | Cell Collective
Models,MultiomicsHCC1954 Breast Cell Line Short-term ErbB Network
Background Despite promising progress in targeted breast cancer therapy, drug resistance remains challenging. The monoclonal antibody drugs trastuzumab and pertuzumab as well as the small molecule inhibitor erlotinib were designed to prevent ErbB-2 and ErbB-1 receptor induced deregulated protein sig...
2700 | Cell Collective
Models,MultiomicsSKBR3 Breast Cell Line Short-term ErbB Network
Background Despite promising progress in targeted breast cancer therapy, drug resistance remains challenging. The monoclonal antibody drugs trastuzumab and pertuzumab as well as the small molecule inhibitor erlotinib were designed to prevent ErbB-2 and ErbB-1 receptor induced deregulated protein sig...
2701 | Cell Collective
Sort   by:  
 Page size